ThermoGenesis Holdings, Inc.

THMO

US88362L2097

Office Equipment

Market Closed - OTC Markets Other stock markets 12:25:31 2025-06-17 pm EDT			5-day change	1st Jan Change
0.000001 ^USD	-99.00%		0.00%	-99.86%

2024	ThermoGenesis Holdings, Inc. Announces Resignation of Jeffery Cauble as Chief Financial Officer	CI
2024	ThermoGenesis Holdings, Inc. Receives A Notice of Default from Boyalife Group, Inc	CI

ThermoGenesis Holdings, Inc.(NasdaqCM:THMO) dropped from S&P TMI Index

Published on 06/19/2024 at 18:00

Latest news about ThermoGenesis Holdings, Inc.

ThermoGenesis Holdings, Inc. Announces Resignation of Jeffery Cauble as Chief Financial Officer	24-07-16	CI
ThermoGenesis Holdings, Inc. Receives A Notice of Default from Boyalife Group, Inc	24-07-11	CI
ThermoGenesis Holdings, Inc. Announces Board and Committee Resignations	24-06-26	CI
ThermoGenesis Holdings, Inc.(NasdaqCM:THMO) dropped from S&P TMI Index	24-06-19	CI
ThermoGenesis Holdings, Inc.(OTCPK:THMO) dropped from NASDAQ Composite Index	24-06-13	CI
Wall Street Set to Open Higher Wednesday as Key Inflation Data Lower Than Expected	24-06-12	MT
US Futures Slightly Higher Ahead of Fed's Rate Decision, Key Inflation Data	24-06-12	MT
Top Premarket Decliners	24-06-12	MT
ThermoGenesis Corp. Enters into A Manufacture and Supply Agreement with CBR Systems, Inc	24-06-04	CI
ThermoGenesis Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	24-05-17	CI
ThermoGenesis Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	24-04-16	CI
ThermoGenesis Holdings, Inc. Auditor Raises 'Going Concern' Doubt	24-04-15	CI
North American Morning Briefing : Traders Await -2-	24-04-10	DJ
North American Morning Briefing : Powell Awaited -2-	24-04-03	DJ
Thermogenesis Holdings, Inc. Announces Resignation of Haihong Zhu, Chief Operating Officer and A Director from the Board	24-03-12	CI
ThermoGenesis Files $30 Million Mixed Shelf	23-11-24	MT
ThermoGenesis Holdings, Inc., Q3 2023 Earnings Call, Nov 13, 2023	23-11-13
ThermoGenesis Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	23-11-13	CI
ThermoGenesis Holdings, Inc. to Open a New 35,500 Square Foot ReadyStart-IncuStart cGMP Facility in Greater Sacramento	23-10-26	CI
ThermoGenesis Holdings, Inc. Announces Management Changes	23-08-29	CI
ThermoGenesis Holdings, Inc., Q2 2023 Earnings Call, Aug 10, 2023	23-08-10
ThermoGenesis Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-10	CI
ThermoGenesis Holdings, Inc. announced that it has received $1 million in funding	23-07-30	CI
ThermoGenesis Holdings, Inc. Announces Board Appointments	23-07-19	CI
Top Premarket Gainers	23-06-06	MT

Chart ThermoGenesis Holdings, Inc.

Duration

Period

THMO: Dynamic Chart

ThermoGenesis Holdings, Inc. develops and commercializes a range of automated technologies for cell-banking, cell-processing, and cell-based therapeutics. The Company provides the AutoXpress and BioArchive platforms for automated clinical bio-banking, the PXP platform for point-of-care cell-based therapies and X-Series products for cell processing services. Its product lines include Clinical Bio-Banking Applications, Point-of-Care Applications and Cell Processing. Its Clinical Bio-Banking Applications include AXP II Automated Cell Separation System and BioArchive Automated Cryopreservation System. Its Point-of-Care Applications include PXP Point-of-Care System, and PXP-1000 System. Its Cell Processing includes X-Series Products for general laboratory use: X-Lab for cell isolation, X-Wash System for cell washing and reformulation, and X-Mini for high efficiency small scale cell purification. The Company markets and sells its medical device products through independent distributors.

Employees

Sector

Office Equipment

More about the company